Replies to post #745003 on NorthWest Biotherapeutics Inc (NWBO)

[CaptainObvious]

Right down the road from me

[ATLnsider]

Thanks for posting this link. I find it interesting that Vitrian is based in Bethesda, Maryland, and the President / CEO of the CDMO AmplifyBio is J. Kelly Ganjei.

As we know, J. Kelly Ganjei, was the past CEO of Cognate, before Cognate was acquired by Charles Rivers Laboratories (CRL), and J. Kelly Ganjei also worked with Linda Powers at Toucan Capital.

[ATLnsider]

Truthfan, I also posted your link on Twitter (X). This could be the answer to which CDMO will be manufacturing DCVax for the North America markets (US, Canada and Mexico).

Stay tuned… 😁

[dstock07734]

Truthfan,

Did you see the pipeline of this AI company which is using AI and omics for drug development? I am certain the two board members know very well about DCVax-L.
The company also has SoftBank as investor.

What I found interesting is that last August when I took the screen of the company's pipeline, oncology was listed as shown below. Now it is gone. It reminds me a company called EVOQ which is developing treatments using DCs. The company has collaborations with both Amgen and Gilead. At first, EVOQ also included oncology in its pipeline. But later, EVOQ only targets autoimmune diseases.

I feel like Oncology is totally LP's domain or empire.


https://www.insitro.com/leadership/roger-perlmutter-m-d-ph-d/
https://www.insitro.com/leadership/eli-casdin/

https://www.evoqtherapeutics.com/
https://www.europeanpharmaceuticalreview.com/news/178150/gilead-658-5m-immunotherapy-collaboration/
https://www.prnewswire.com/news-releases/evoq-therapeutics-and-amgen-expanding-collaboration-301724006.html